{"title":"Seroepidemiology of HBV and HCV in Bangladesh","authors":"Mobin Khan, N. Ahmad","doi":"10.1016/S0928-4346(96)82007-X","DOIUrl":null,"url":null,"abstract":"<div><p>Virus related liver diseases are important causes of morbidity in Bangladesh. We have reviewed the data of different authors to assess the magnitude of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in this country. HBV accounts for 35% acute viral hepatitis, 40.5% chronic liver disease, 36.5% hepatocellular carcinoma and 29.1% cases of post transfusion hepatitis. HCV accounts for 3.5% acute viral hepatitis, 24.1% chronic liver disease, 9.6% hepatocellular carcinoma and 6.8% cases of post transfusion hepatitis. Blood donors are not routinely screened for HBsAG except in a few selected centers. Twenty-nine percent of professional blood donors and 2.4% of voluntary blood donors are HBsAG carriers. Anti-HCV was found in 1.2% of professional blood donors and in no voluntary donors. HBsAG is positive in 7.5% of healthy adult jobseekers. In our series of acute viral hepatitis, there was no history suggestive of parenteral route of infection in 60% cases of HBV and 54% cases of HCV. In conclusion, HBV is the main aetiological factor for chronic liver disease in Bangladesh.</p></div>","PeriodicalId":13746,"journal":{"name":"International Hepatology Communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1996-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0928-4346(96)82007-X","citationCount":"39","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Hepatology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S092843469682007X","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 39
Abstract
Virus related liver diseases are important causes of morbidity in Bangladesh. We have reviewed the data of different authors to assess the magnitude of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in this country. HBV accounts for 35% acute viral hepatitis, 40.5% chronic liver disease, 36.5% hepatocellular carcinoma and 29.1% cases of post transfusion hepatitis. HCV accounts for 3.5% acute viral hepatitis, 24.1% chronic liver disease, 9.6% hepatocellular carcinoma and 6.8% cases of post transfusion hepatitis. Blood donors are not routinely screened for HBsAG except in a few selected centers. Twenty-nine percent of professional blood donors and 2.4% of voluntary blood donors are HBsAG carriers. Anti-HCV was found in 1.2% of professional blood donors and in no voluntary donors. HBsAG is positive in 7.5% of healthy adult jobseekers. In our series of acute viral hepatitis, there was no history suggestive of parenteral route of infection in 60% cases of HBV and 54% cases of HCV. In conclusion, HBV is the main aetiological factor for chronic liver disease in Bangladesh.